Boehringer Ingelheim reaches more patients than ever in 2022 as innovative medicines drive growth

INGELHEIM, Germany — (BUSINESS WIRE) — Boehringer Ingelheim today reported a strong performance in 2022, a year in which 30 million patients benefited from its innovative medicines, while …